These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31989649)

  • 41. Aptamer decorated hyaluronan/chitosan nanoparticles for targeted delivery of 5-fluorouracil to MUC1 overexpressing adenocarcinomas.
    Ghasemi Z; Dinarvand R; Mottaghitalab F; Esfandyari-Manesh M; Sayari E; Atyabi F
    Carbohydr Polym; 2015 May; 121():190-8. PubMed ID: 25659689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colossolactone-G synergizes the anticancer properties of 5-fluorouracil and gemcitabine against colorectal cancer cells.
    Algehani RA; Abou Khouzam R; Hegazy GA; Alamoudi AA; El-Halawany AM; El Dine RS; Ajabnoor GA; Al-Abbasi FA; Baghdadi MA; Elsayed I; Hattori M; Al-Abd AM
    Biomed Pharmacother; 2021 Aug; 140():111730. PubMed ID: 34062410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
    Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro co-delivery of 5-fluorouracil and all-trans retinoic acid by PEGylated liposomes for colorectal cancer treatment.
    Azarifar Z; Amini R; Tanzadehpanah H; Afshar S; Najafi R
    Mol Biol Rep; 2023 Dec; 50(12):10047-10059. PubMed ID: 37902908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
    Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
    Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
    Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
    Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer.
    Du W; Yang X; He S; Wang J; Guo Y; Kou B; Jiang Y; Bian P; Li B; Yin L
    Drug Deliv; 2021 Dec; 28(1):920-929. PubMed ID: 33974471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
    Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
    Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
    Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M
    Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells.
    Sharma A; Kaur A; Jain UK; Chandra R; Madan J
    Colloids Surf B Biointerfaces; 2017 Jul; 155():200-208. PubMed ID: 28431329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-assembling HA/PEI/dsRNA-p21 ternary complexes for CD44 mediated small active RNA delivery to colorectal cancer.
    Feng CL; Han YX; Guo HH; Ma XL; Wang ZQ; Wang LL; Zheng WS; Jiang JD
    Drug Deliv; 2017 Nov; 24(1):1537-1548. PubMed ID: 28994324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer.
    Smith T; Affram K; Nottingham EL; Han B; Amissah F; Krishnan S; Trevino J; Agyare E
    Sci Rep; 2020 Oct; 10(1):16989. PubMed ID: 33046724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
    Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
    Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5-Fluorouracil enteric-coated nanoparticles for improved apoptotic activity and therapeutic index in treating colorectal cancer.
    Tummala S; Kuppusamy G; Satish Kumar MN; Praveen TK; Wadhwani A
    Drug Deliv; 2016 Oct; 23(8):2902-2910. PubMed ID: 26634385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A natural flavonoid lawsonaringenin induces cell cycle arrest and apoptosis in HT-29 colorectal cancer cells by targeting multiple signalling pathways.
    Anwar A; Uddin N; Siddiqui BS; Siddiqui RA; Begum S; Choudhary MI
    Mol Biol Rep; 2018 Oct; 45(5):1339-1348. PubMed ID: 30088202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.
    Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB
    Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
    Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer.
    Mahira S; Kommineni N; Husain GM; Khan W
    Biomed Pharmacother; 2019 Feb; 110():803-817. PubMed ID: 30554119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.